Attached files

file filename
10-K - MAINBODY - Rich Pharmaceuticals, Inc.mainbody.htm
EX-31.1 - EX31_1 - Rich Pharmaceuticals, Inc.ex31_1.htm
EX-24.1 - EX24_1 - Rich Pharmaceuticals, Inc.ex24_1.htm
EX-21.1 - EX31_1 - Rich Pharmaceuticals, Inc.ex21_1.htm
EX-31.2 - EX31_2 - Rich Pharmaceuticals, Inc.ex31_2.htm
EXCEL - IDEA: XBRL DOCUMENT - Rich Pharmaceuticals, Inc.Financial_Report.xls
EX-10.6 - EXHIBIT 10.6 - Rich Pharmaceuticals, Inc.ex10_6.htm
EX-14.1 - EX14_1 - Rich Pharmaceuticals, Inc.ex14_1.htm

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual Report of Rich Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the year ended March 31, 2014 filed with the Securities and Exchange Commission (the “Report”), I, Ben Chang, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1.The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

2.The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.

 

By: /s/ Ben Chang
Name: Ben Chang
Title: Principal Executive Officer, Principal Financial Officer and Director
Date: July 15, 2014

 

This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.